![Jaume Pons](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jaume Pons
Fondatore presso
Alx Oncology Ltd.
Patrimonio netto: 959 755 $ in data 31/07/2026
Profilo
Jaume Pons is the founder of ALX Oncology Ltd., founded in 2015, serving as President, Chief Executive Officer & Director.
Dr. Pons was the founder of ALX Oncology Holdings, Inc., founded in 2015, and served as President & Chief Scientific Officer from 2024 to 2025.
Dr. Pons is the founder of Tallac Therapeutics, Inc., founded in 2018, serving as Director.
Dr. Pons is also the founder of ALX Oncology, Inc...
Dr. Pons currently serves as Director at Alexo Therapeutics International.
Dr. Pons currently serves as Director at Sirpant Therapeutics.
Dr. Pons currently serves as Scientific Advisor at LSV Capital Management LLC.
Formerly, Dr. Pons was Chief Scientific Officer at Pfizer Inc. from 2007 to 2015.
Formerly, Dr. Pons was Chief Scientific Officer at Rinat Neuroscience Corp.
from 2007 to 2015.
Formerly, Dr. Pons was Venture Partner at venBio Partners LLC.
Dr. Pons completed graduate studies at the University of California, Berkeley in 1999.
Dr. Pons completed undergraduate, graduate, and doctorate degrees at the Autonomous University of Barcelona.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 494.719 ( 0,37% ) | 959 755 $ | 31/07/2026 |
Posizioni attive di Jaume Pons
| Società | Posizione | Inizio |
|---|---|---|
Alx Oncology Ltd.
 Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company developing immuno-oncology therapies for cancer | Fondatore | 01/04/2015 |
Alexo Therapeutics International
 Alexo Therapeutics International Pharmaceuticals: MajorHealth Technology Alexo Therapeutics International develops immune-oncology therapies for cancer. The company is headquartered in South San Francisco, CA. | Direttore/Membro del Consiglio | - |
Tallac Therapeutics, Inc.
 Tallac Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in research and development of immunomodulation polynucleotides | Fondatore | 01/01/2018 |
Sirpant Therapeutics | Direttore/Membro del Consiglio | - |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Consulente / Consigliere | - |
Precedenti posizioni note di Jaume Pons
| Società | Posizione | Fine |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Amministratore Delegato | 06/09/2023 |
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Direttore Tecnico/Scientifico/R&S | 01/02/2015 |
| PFIZER INC. | Direttore Tecnico/Scientifico/R&S | - |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers | Amministratore Delegato | - |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ | - |
Formazione di Jaume Pons
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
75
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Health Technology |
venBio Partners LLC
 venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor. | Finance |
Autonomous University of Barcelona
 Autonomous University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Alx Oncology Ltd.
Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company developing immuno-oncology therapies for cancer | Health Technology |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers | Health Technology |
Tallac Therapeutics, Inc.
Tallac Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in research and development of immunomodulation polynucleotides | Health Technology |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
Alexo Therapeutics International
Alexo Therapeutics International Pharmaceuticals: MajorHealth Technology Alexo Therapeutics International develops immune-oncology therapies for cancer. The company is headquartered in South San Francisco, CA. | Health Technology |
Sirpant Therapeutics |
